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ABSTRACT 
 
With its capacity to survey the environment and phagocyte debris, microglia 
assume a diversity of phenotypes to specifically respond through neurotrophic 
and toxic effects. While these roles are well accepted, the underlying energetic 
mechanisms associated with microglia activation remain largely unclear.  In this 
paper, microglia metabolic adaptation to ATP, NADPH,H+ and ROS production 
was investigated. To this end, in vitro studies were performed in BV-2 cells 
before and after activation with LPS+IFNγ. NO was measured as a marker of 
cell activation. Our results show that microglia activation triggers a metabolic 
reprogramming based on an increased glucose uptake and a strengthening of 
anaerobic glycolysis, as well as of the pentose pathway oxidative branch, while 
retaining the mitochondrial activity. Based on this energy commitment, microglia 
defense capacity increases rapidly as well as ribose-5-phosphate and nucleic 
acid formation for gene transcription, essential to ensure the new acquired 
functions demanded by CNS signaling. In discussion, we review the role of NO 
in this microglia energy commitment that positions cytotoxic microglia within the 
energetics of the astrocyte-neuron lactate shuttle.  
 
Key words: 
Glutamate-glutamine cycle, glycolysis, lactate, Nitric Oxide, Pentose phosphate 
pathway 
 
 
 
 3 
Introduction 
 
In the central nervous system (CNS), quiescent microglia constitutes the first 
line of defense (Falsig et al. 2008) that reacts to acute damage or infectious 
agents. In a dynamic equilibrium between the lesion progression and the 
environment, microglia adopts a diversity of phenotypes ranging from the pro-
inflammatory M1 to the neurotrophic M2 (Luo and Chen 2012).  So, in response 
to a diversity of signals, the microglia transition to an activated state implies 
migration to the lesioned area, induction of phagocytosis, massive changes in 
gene expression, and reorganization of the cell phenotype to directly modify 
neuronal survival. Thus, in the same environment activated microglia interferes 
the responses of supporting cells through release of a diversity of factors 
(Kettenmann et al. 2011). 
Microglia express a broad set of genes encoding proteins that include but are 
not limited to cytokines, chemokines, neurotrophins, neurotoxic factors, and 
proteases. Depending on the intensity of damage and the time post-injury, a 
crosstalk with neurons and astrocytes induces adaptation of the microglia 
phenotype to favor debris clearance, necrosis, tissue repair or regeneration  (De 
Yebra et al. 2006). For example, with a proper timing and mode of activation, 
microglia work as efficient antigen-presenting cells that stimulate T cells and 
affect the milieu balance between neurotrophism and cytotoxicity. 
Reactive microglia mediate this diversity of processes in coordination with 
reactive astrocytes, and both cell types depend on glucose metabolism for 
feeding their activities. After glucose uptake, Hexokinase (HK; E.C. 2.7.1.1) 
mediates glucose phosphorylation, yielding glucose-6-phosphate (G6P), a 
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common precursor of glycolysis for energy and lactate production, and of the 
pentose–phosphate pathway (PPP). In microglia, the PPP not only renders 
ribose-5-phosphate for nucleic acid synthesis, but also NADPH+H+ redox 
equivalents through its oxidative branch, to be transformed at the external 
cytoplasm membrane by NADPH oxidase (E.C. 1.6.3.1) in superoxide ions for 
defense and oxidative stress (Wu et al. 2006; Yang et al. 2007). The rate-
limiting step in glycolysis activity is catalyzed by 6-phosphofructokinase (PFK1; 
E.C. 2.7.1.11), and in PPP activity by glucose-6-phosphate dehydrogenase 
(G6PD; E.C. 1.1.1.49). The interconnected reactions between these two 
pathways facilitate a direct and rapid metabolic modulation that covers at each 
moment the cell demand in these diverse end products.  
Presently, the adaptation of glucose pathways to feed microglia diversity of 
phenotypes remains unknown, and we hypothesized that it might in part mimic 
the adaptation described in astrocytes.  In astrocytes, nitric oxide (NO) 
formation triggers a very rapid PFK1 activation that potentiates anaerobic 
glycolysis versus the oxidative phosphorylation (OXPHOS). This metabolic 
transition preserves astrocytes from ATP depletion and maintains their 
mitochondrial membrane potential (Almeida et al. 2004b).  
To this end, in vitro metabolic studies were performed in BV-2 microglia, a 
suitable alternative model of primary culture (Henn et al. 2009), before and after 
activation with LPS+ IFNγ, and NO production measured in each condition 
(Blasi et al. 1990). Here we provide evidences that, associated with NO 
formation, activation of microglia triggers a metabolic reprogramming based on 
an increased glucose uptake and a potentiation of both the anaerobic glycolysis 
and the oxidative branch of PPP, while retaining a mitochondrial activity. 
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Essential to ensure the new functions of activated microglia, ribose-5-phosphate 
availability for nucleic acid synthesis and gene transcription increases rapidly as 
well as ATP, lactate and NADPH+H+. In Discussion the role of microglia lactate 
formation and glutamate uptake is considered positioned within the 
neuroenergetics of the astrocyte-neuron lactate shuttle (ANLS) (Bouzier-Sore et 
al. 2003; Magistretti 2006; Magistretti and Chatton 2005; Pellerin and Magistretti 
2012) of a four-partite synapse, in which lactate is shuttling to neurons not only 
from astrocytes but also from microglia (Rodríguez MJ 2013). 
 
Materials and methods 
 
Materials 
 
Cell line of murine BV-2 microglia was purchased from Cell Bank (Interlab Cell 
Line Collection, ICLC, Geneva, Italy).  RPMI medium supplemented with L-
glutamine was purchased from GIBCO (Oklahoma, USA). Fetal Bovine Serum 
(FBS), was from VWR Scientific (San Francisco, USA). Culture plates and 
flasks were purchased from Nunc (Roskilde, Denmark). Lipopolysaccharide 
(LPS) from Escherichia coli 0111:B4 and interferon-gamma (IFNγ) and all 
metabolites and enzyme reagents were purchased from Sigma (St. Louis, 
USA). 
 
BV-2 cell culture 
BV-2 cells were cultured in RPMI 1640 medium with L-glutamine and 
supplemented with 10% (v/v) heat-inactivated FBS, 100 U/ml penicillin and 100 
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µg/ml streptomycin. Cells were grown in a humidifier cell incubator containing 
5% CO2 at 37 °C. Before activation, cells were cultured at a density of 5 × 104 
cells/ml for 24 h and flasks were divided into 3 groups: a) One group with no 
further manipulation, called Control, b) the LPS+ IFNγ group, in which BV-2 
cells were activated with LPS+ IFNγ (0.1 µg/ml and 0.5 ng/ml respectively) for 
24 hours, and c) the IL-4 group, in which BV-2 cells were stimulated with IL-4 
(0.5 µg/ml) for 24 hours. 
 
Inhibition of NO synthesis in LPS+IFNγ stimulated BV-2 cells 
In order to inhibit NO formation, BV-2 cells activated with LPS+IFNγ were 
incubated with 2.5 mM Nω-nitro-l-arginine (NLA), a potent inhibitor of nitric 
oxide synthase (NOS) (Molnár and Hertelendy 1992). 
 
Quantification of NO and TNFα production by BV-2 cells 
NO production was assessed in culture supernatants by the Griess reaction, a 
colorimetric assay that detects nitrite (NO2−) as a stable reaction product of NO 
with molecular oxygen (Green et al., 1982). Briefly, 50 µl of each sample were 
incubated with 25 µl of Griess reagent A (1% sulfanylamide, 5% phosphoric 
acid) and 25 µl of Griess reagent B (0.1% N-1-naphthylenediamine) for 5 min. 
Sample optical density was measured at 540 nm with a microplate reader 
(Sunrise-Basic Reader, TECAN). The nitrite concentration was determined from 
a sodium nitrite standard curve. TNFα released in the cell culture supernatant 
was determined by an ELISA murine TNFα kit (PeproTech; London, UK) 
following the manufacturer's guidelines. 
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Real-time RT-PCR 
Total RNA from microglial cells was isolated using the NucleoSpin® 
RNA/Protein kit (Qiagen Inc., Hilden, Germany) according to the manufacturer's 
instructions. Then 2 µg of first-strand cDNA was synthesized with random 
primers using the First Strand cDNA Synthesis kit. The RT reaction was 
performed at 42°C for 60 minutes and then at 70°C for 5 minutes. Real-time 
PCR was conducted using SensiFAST®  SYBR No-ROX One-Step mix and 
Applied Biosystems (Foster, CA) Stem One Plus® Real Time PCR Systems 
according to manufacturer’s instructions. The PCR program was:  
2 minutes at 95°C for denaturation, subsequently 45 cycles of 15 seconds at 
95°C for amplification, and 1 minute at 60°C for final extension.. The level of 
mRNA expression was determined with a standard curve and normalized to the 
mRNA level of B2m. The PCR primer of B2m endogenous control, glucose 
transporters (GLUT) -1, -2 -3, -4, and -5, and glucokinase (GK) target genes 
were purchased from RealTimePrimers (Elkins Park PA, USA) The ΔΔCT 
method was used to analyze the data as described by Bookout et al. (2006). 
Primer sequences  for target gene and endogenous controls are presented in 
Table 1. 
 
Glucose consumption and Lactate production 
Culture medium was collected from control and LPS+IFNγ activated BV-2 cells 
at time 0 and 24 hours. Then glucose and lactate levels were determined with 
an ADVIA® 2400 Clinical Chemistry System (Siemens Healthcare Diagnostics, 
Tarrytown, USA) that uses the glucose oxidase method described by Barham 
and Trinder (Barham and Trinder 1972) and the method of Shimojo (Shimojo et 
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al. 1989) for lactate measurement. For statistical analysis of lactate release, a 
normal distribution of data was assumed (Voisin et al. 2010). 
 
Lysate preparation and enzyme activity determination 
Cells were grown to confluence, transferred to a 15 ml Falcom® tube (BD 
Biosciences, California, USA), centrifuged at 1000x g at RT for 10 min. Pelleted 
cells were washed in 10 ml PBS 10 mM PH=7.4, counted in a Neubauer 
counting chamber and centrifuged again. The pellet was suspended in enough 
amount of ice-cold lysis buffer (50 mM Tris-HCl, 4 mM EDTA, 50 mM FK, 0,1% 
(v/v) Triton X-100, PH=7) to have 107 cells/ml, transferred to a 1.5 ml centrifuge 
tube and homogeneized (Potter’s Homogeneizer) at 11000 min-1. Then, the cell 
lysate was centrifuged at 14000 g for 15 min at 4ºC. The supernatant fraction 
was transferred to a centrifuge tube and stored at 4ºC until the enzymatic assay 
was performed. 
 
The enzyme activities of HK, PFK1, G6PDH and lactate dehydrogenase (LDH; 
E.C. 1.1.1.27) were estimated spectrophotometrically in BV-2 lysate 
supernatants. The assays were performed at 30°C in 1 ml final volume 
incubation buffer added with 100 µl cell supernatant in a Beckman Coulter 
(Brea, USA) recording spectrophotometer. Then concentration of NADH or 
NADPH was monitored by measuring absorbance at 340 nm. One unit of 
enzyme activity (U) is defined as µmol/min, and specific activity is expressed as 
U/nºcells. 
 
HK activity was assayed by measuring the rate of reduction of NADP+ by 
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glucose 6-phosphate dehydrogenase (Bergmeyer 1983). The assay medium 
contained Tris-HCl 50 mM, MgSO4 80 mM, EDTA 20 mM, KCI 1.5 mM, 
mercaptoethanol 2mM, NADP+ 3 mM, ATP 2.5 mM, Triethanolamine 200 mM, 
Glucose 1 mM. 
 
PFK1 activity was measured by measuring changes in the absorbance of NADH 
in a coupled enzyme assay (Beutler 1975). The assay buffer consisted of Tris-
HCl 50 mM, pH 7.4, MgCl2 100 mM, EDTA 5 mM, aldolase (mouse muscle, 
0.04 U/ml), triose phosphate isomerase (mouse muscle, 2.4 U/ml), GAPDH 
(mouse muscle, 0.32 UI/ml) and 1mM of fructose 6-phosphate and ATP. 
 
Lactate dehydrogenase activity was measured using the method previously 
described by Hakala (Hakala et al. 1956). The assay buffer consisted of Tris-
HCl 50mM PH=7.5, NADH 2 mM and pyruvate 20mM.  
 
G6PDH activity was assayed as described by Bishop (Bishop 1966). The assay 
medium contained 380 mM glycine, 304 mM hydrazine, 83 mM Lactate and 2,6 
mM NAD disodium salt. 
 
Confocal imaging of mitochondrial membrane potential  
Mitochondrial membrane potential (∆Ψm) was measured by confocal imaging of 
BV-2 cells loaded with the fluorescent probe tetramethylrhodamine ethyl ester 
(TMRE) (Molecular Probes, Eugene Oregon), as previously described (Baczkó 
et al. 2004). In brief, cells were first incubated in 6 well-plates for 30 min in 
medium containing TMRE (50 nM) and then washed with fresh medium. 
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Afterwards, cells were incubated in the presence of 50 nM TMRE during the 
imaging process. Cell fluorescence was acquired by sequential scanning at the 
510 nm emission wavelength. Cell average pixel intensity was obtained as an 
average of measurements done in 4 fields of each one of 3 culture wells. 
Confocal images were obtained using Zeiss Observer.Z1® microscope coupled 
to a Retiga EXi Fast 1394® camera, objective LD 20X/0.4 DICII (resolution 0.83 
µm). 
 
Software and Data analysis 
Statistical studies and graphics were performed with Statgraphics® (STSC Inc., 
Rockville, USA) and Graphpad Prism® (GraphPad Software Inc., La Jolla, 
USA). For each parameter, Kurtosis and Skewness moments were calculated to 
test the normal distribution of data. One-way ANOVA test was used to analyse 
differences between the groups. In all cases p<0.05 was considered statistically 
significant.  
Image acquisition was performed using Fluo4® software (Exploranova, 
Bordeaux, France). Figure 5 was produced using Servier Medical Art archive 
(Les laboratoires servier, Suresnes, France) 
 
 
Results 
 
BV-2 cell activation increases glucose uptake and its phosphorylation  
 
BV-2 cell activation was monitored by estimation of NO and TNFα release 24h 
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after activation with LPS+IFNγ. At this time, LPS+IFNγ increased 6 fold NO 
production (from 4.89± 0.85 to 29.62± 1.96 p<0.0001) and TNFα 3.5-fold (from 
534.88 ± 113.94 to 1948.58 ± 333.32 p<0.0001) when compared with controls.   
 
BV-2 glucose consumption was compared between control and LPS+INFγ 
activated cells. In both situations, glucose was measured in the culture medium 
at time 0 and 24h, and results were referred to the BV-2 cell number. After 
activation, glucose consumption increased significantly in a fold change of 1.37 
(Figure 1A, 2D). 
 
An increased energy demand requires greater microglia usage of glucose, and 
in other cells this is facilitated by the increased activity of Hexokinase to retain 
glucose within the cell, and also by the increased expression of GLUT. To 
estimate the effect of cell activation on the glucose uptake and consumption by 
microglia we determined the HK specific activity and the expression of GK and 
the five main species of GLUT. Relative to control, LPS+IFNγ promoted a 
significant 1.9-fold increase of HK specific activity in the soluble fraction of cell 
lysate (Figure 1B, 2D). BV-2 glucokinase expression was analyzed by RT-
qPCR. mRNA of this enzyme was amplified from total RNA isolated from control 
BV-2 cells, and no change was found after LPS+IFNγ activation (data not 
shown).  
 
To identify which of the five members of the GLUT family are expressed in 
microglia, mRNA of GLUT-1 to -5 was analyzed in control cells by RT-qPCR.  
GLUT-1 expression resulted largely predominant (91% of total), far from GLUT-
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4 the second in abundance (8,2% of total) (Figure 1C). The very low expression 
of GLUT-2, GLUT-3 and GLUT-5 (< 0,2% of total) was considered negligible 
(Figure 1C). 24h after LPS+IFNγ activation, both GLUT-1 and GLUT-4 
expression resulted similarly increased, but this increase was significant for 
GLUT-4 (p=0.034) and not for GLUT1 (p=0,057). GLUT-2, GLUT-3 and GLUT-5 
levels remained negligible (Figure 1C). 
 
BV-2 cell activation induces a switch of glucose metabolism to anaerobic 
glycolysis and pentose phosphate pathway. 
 
The increased glucose uptake and its phosphorylation measured in activated 
BV-2 cells may indicate an enhancement of anaerobic glycolysis, supported by 
the increased activity of PFK1, the key regulatory enzyme of the glycolytic rate. 
This enhancement is sometimes associated with an increased ROS production 
at the plasma membrane facilitated by the increased activity of G6PDH, the 
regulatory enzyme of the PPP. 
Consistent with this possibility, G6PDH specific activity was determined in the 
soluble fraction of cell lysate, together with PFK1 and LDH specific activities 
and lactate extracellular concentration. Relative to control, LPS+IFNγ activation 
promoted at 24h a significant increase of G6PDH specific activity in a 1.95 fold 
change (p=0.004, Figure 2A,D). PFK1 specific activity resulted also significantly 
increased in a 1.14 fold change (p=0.0014, Figure 2B,D), and the same 
occurred with LDH activity, increased in a fold change of 1.4 (p<0.0001, Figure 
2C,D). 
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Compared to control, lactate production was doubled in the activated cells, as 
evidenced at 24h by its 2.02-fold increased concentration in the culture medium 
(p=0.019). Besides the increased glucose uptake of the activated cells, the 
lactate level represents an increased and massive transformation of G6P into 
lactate, supported by a glucose/lactate ratio from 1.266 in controls to 1.874 in 
activated cells. 
This massive lactate production could be attributed to a reduced mitochondrial 
activity and a switch to anaerobic glycolysis of the activated cells. This was 
assessed through a time-lapse confocal imaging of the inner membrane 
potential (ΔΨm) at 24h in control and activated cells with the mitochondrial 
membrane potential sensitive dye TMRE (3A). In both situations, the frequency 
distribution of mitochondria fluorescence followed a normal distribution and was 
similar in their absolute value and relative frequency distribution (Figure 3B). 
The lack of ΔΨm difference herein found indicates that the activated cells 
maintain their electron transport chain usage besides their anaerobic glycolysis 
switch and their increased PPP.  
 
NO formation participates of the activated BV-2 cells glycolitic activation 
 
Involvement of NO in the metabolic reprogramming of LPS+IFNγ activated BV-2 
cells was studied after 2’5 mM Nω-nitro-l-arginine inhibition of iNOS for 24h. 
Glucose and lactate were measured in the culture medium at time 0 and 24h, 
and results referred to the BV-2 cell number. iNOS inhibition resulted in a 
decreased of both glucose consumption (fold change of 0.82, p=0.02) and 
lactate release (fold change of 0.63, p<0.001) (Figure 4A, B), back to control 
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values. No significant change in G6PDH was found (Figure 4C), indicating that 
its activation is independent from NO.  
 
BV-2 cells adoption of a phagocytic phenotype activates a new metabolic 
reprogramming  
 
To determine whether our results also apply to the adoption of a phagocytic 
phenotype, BV-2 cells were stimulated with IL-4 (0.5 µg/ml) for 24h.  Glucose 
and Lactate were both measured in the culture medium at time 0 and 24h, and 
G6PDH activity in the homogenate as usually. With regard to control, glucose 
consumption was 30% reduced (p< 0.001) and lactate production 43% (p< 
0.006), whereas G6PDH activity resulted unchanged. In these conditions, the 
maintenance of the PPP ensures NADPH+H+ redox equivalents to be 
transformed in superoxide ions for phagocytosis as G6DPH strongly increases 
its activity with higher NADP+ level. The new biomolecules delivered by 
phagocytosis directly available to the BV-2 cells would reduce at least in part 
the need of anabolic reactions and thus the cell energy demand. This possibility 
requires further experiments to be validated. 
 
Discussion 
BV- 2 cells were used to investigate the microglia adaptation to an excitotoxic 
phenotype. This cell line is considered a suitable alternative model of primary 
culture or of many animal studies (Henn et al. 2009) (Stansley et al. 2012). For 
example, 90% of the genes induced in BV-2 by LPS activation are also found in 
primary microglia, including the Nitric Oxide synthase (iNOS) gene. 24h after 
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incubation with LPS+IFNγ, BV-2 cells increased NO and TNFα production that 
is related with an enhancement of cell inflammatory activity (Ortega et al. 2013).  
In these conditions, the main finding of this study is the coordinated response of 
the glucose pathways necessary to cover the cell demand and enable the 
microglia response to activation. This metabolic reprogramming is different with 
microglia adoption of a phagocytic phenotype as the delivery of new 
biomolecules may reduce the cell energy demand. In astrocytes LPS 
stimulation induced NO production leading to an increased glucose 
consumption and lactate release (Bolaños et al. 1994) and an increased PPP 
activity to prevent glutathione depletion and increase astrocyte resistance to NO 
mediated cellular damage (García-Nogales et al. 1999). After exposure to 
peroxinitrite, the maintenance of astrocyte mitochondrial activity and its 
reduction in neurons also demonstrates the astrocytic resistance capacity to NO 
damage (Bolaños et al. 1995). The direct NO participation in the microglia 
metabolic reprogramming shown by our data reinforces the similarity with the 
astrocyte metabolic adaptation to excitotoxicity. As such, the increased HK 
activity and increased GLUT1 and GLUT4 expression ensure enough glucose 
availability to the cell. GLUT1 expression in control microglia was much higher 
than GLUT4, with similar changes 24h after activation. Because of that, these 
two transporters can be considered constitutive of microglia.  
  
GLUT1 is a high-affinity glucose transporter, which expression in tumor cells is 
stimulated under hypoxic conditions. And this adaptation also includes 
enhancement of the glycolysis rate to support the increased energy demand of 
the proliferative cells (Bashan et al. 1992; Haber et al. 1998). The HK and 
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GLUT1 increases herein found would then reflect the microglia adaptation to an 
enhanced glycolytic demand with a high lactate production, and high metabolic 
rate. GLUT4 expression is modulated in brain and pancreas by ATP dependent 
potassium (KATP) channels whose activity depends on glucokinase (Choeiri et 
al. 2006). In agreement with previous brain studies (Alvarez et al. 2002) the low 
glucokinase Km that renders the enzyme unable to detect glucose 
concentration increase may explain the unchanged glucokinase expression in 
activated microglia. The increased KATP channel expression described in 
activated microglia (Ortega et al. 2012; Ramonet et al. 2004b) may then 
participate in the GLUT4 expression increase. If true, the similar changes of 
GLUT1 and GLUT4 shown by our results suggest a coordinated microglia 
control of their expression that may depend, at least in part, on KATP channel 
activity. As observed in taste cells (Yee et al. 2011), this would represent a fine 
coordination between activation of microglia and increased glucose availability.  
 
Microglia metabolic reprogramming led to a potentiation of anaerobic glycolysis 
reflected by the increased PFK1 and LDH activities and a massive lactate 
formation. In astrocytes increased NO stimulates PFK1 activity through 
allosteric activation with fructose-2,6-bisphosphate (Fru-2,6-P2) produced by 6-
phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Moreover, NO inhibition 
of cytochrome c oxidase switches the glycolytic rate on, with pyruvate 
conversion into lactate recovering NAD+ in the cytosol for glycolysis feed-back 
(Almeida et al. 2004a). The supply of glucose-derived lactate by activated 
microglia would support active neurons, whose elevated energy demand relies 
mostly on mitochondrial ATP production. Thus, with the astrocytes and 
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microglia adapted to a major glucose anaerobic oxidation, lactate represents 
the major neuronal energy source in damaged CNS (Fig 5).  
 
The NO-mediated down-regulation of mitochondrial energy production observed 
in neurons and initially in astrocytes (Bolaños et al. 1994), but afterwards 
considered to be unaffected by the same authors, with similar activities of the 
enzymatic complexes of the Krebs cycle  (Bolaños et al. 1995) was not truly 
observed in microglia. The similar ΔΨm of control and activated BV-2 cells might 
reflect the ATP synthase reversed reaction fed by ATP from glycolysis and 
others (Almeida et al. 2001 PNAS), or could indicate an active electron 
transport chain energy production.  In microglia of damaged brain tissue, the 
higher number of mitochondria labeled with [H3]PK11195 (Bernal et al. 2009; 
De Yebra et al. 2006) and their higher KATP channels expression (Rodríguez MJ 
2013; Virgili et al. 2011) argue in favor of a significant mitochondrial production 
of energy to help ensuring sufficient bioenergetics to execute the new 
transcription programs derived from excitotoxic activation. If true, feeding of the 
Krebs cycle to maintain mitochondria activity cannot rely on pyruvate because 
of its transformation into lactate, but on 2-oxoglutarate formation from glutamate 
and glutamine deamination that increases progressively from apoptotic to 
necrotic damage (Ramonet et al. 2004a).   
Upon activation, microglia express the two glutamate transporters EAAT-1 and -
2 for glutamate and glutamine synaptic extrusion as well as glutamine synthase 
(Gras et al. 2006). Thus, in excitotoxicity, the fast microglial uptake of glutamate 
and glutamine, coordinated with the astrocyte glutamate removal, promotes a 
quick deactivation of the increased synaptic glutamate signal. In astrocytes, the 
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early work by Pellerin et al (1994) describes the glutamate-induced glycolysis to 
facilitate lactate to neurons during physiological activation, and hypothesized for 
the first time the ANLS. With excitotoxicity, microglia glutamate uptake would 
induce a similar stimulatory effect to provide further lactate to neurons, and also 
renders abundant 2-oxoglutarate to ensure the Krebs cycle activity. 
In microglia glutamate deamination renders 2-oxoglutarate and ammonium that, 
combined with CO2 released from the Krebs cycle, forms carbamic acid, a 
precursor of the pyrimidine bases necessary for nucleic acid synthesis and the 
increased gene expression. As in astrocytes (Gradinaru et al. 2012), carbamic 
acid direct clearance and elimination as a stable complex with glucuronides is 
also possible through a detoxification process (Hipkiss 2010; Schafer et al. 
2013).  
In necrotic brain tissue a net glutamine output of the Glutamate/Glutamine cycle 
caused by a reduced neuronal glutaminase activity (Ramonet et al. 2004a) 
increases the microglial formation of 2-oxoglutarate and ammonium and the 
generation of superoxide ions. After reaction with NO, superoxide ions form the 
highly reactive peroxynitrite products, associated with a cytotoxic microglia 
phenotype, and a progressive microglia dysfunction. (Svoboda and 
Kerschbaum 2009). If true, microglia ammonium concentration would represent 
one of the contextual factors that influence the microglial net effects on neuronal 
survival (Luo and Chen 2012) (See Fig. 5). 
The PPP oxidative branch was also increased in activated microglia, as shown 
by the increased G6PDH activity that supports G6P oxidation and NADPH 
formation. In neurons NO facilitates a fine-tuning of G6P destination to 
glycolysis or PPP that potentiates glutathione reduction against oxidative 
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damage. Our data indicate that NO is also directly involved in the metabolic 
reprogramming of microglia, together with a significant contribution of the 
phagosomal NADPH-oxidase to ROS generation and oxidative stress damage 
from G6P (Miller et al. 2007; Wu et al. 2006). Furthermore, the juxtaposition of 
phagosomes and mitochondria recently proposed in microglia (Rodríguez MJ 
2013) should potentiate mitochondrial ROS formation and energy production 
(Dikalov et al. 2012; Murphy 2009) (See Fig. 5).  
 
In conclusion, NO appears to play a key role in the adaptation of activated 
microglia to the energy commitment necessary to ensure its adoption of a 
neurotrophic/cytotoxic phenotype. In these conditions, the coordinated response 
of the four-partite synapse, in which lactate is shuttling to neurons not only from 
astrocytes but also from microglia, has also to include the rapid glutamate 
removal by astrocytes and microglia. Thus, under brain damage, a new player 
should be included in the ANLS initially proposed by Pelerin et al. (1994), 
transforming it into a microglia-astrocyte-neuron lactate shuttle. Further studies 
are needed to determine how reduction of glutaminase activity following 
neuronal damage and the consequent increased ammonium output influence 
the microglia response of increased oxidative damage.  
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Figure legends 
 
Figure 1: 24h after LPS+INFγ activation, the BV-2 increased glucose 
consumption is facilitated by the coordinated increase of hexokinase activity 
and GLUT-1 and GLUT-4 expression. A: Increase of Glucose consumption 
(*p<0.0001 vs control) B: Increase of Hexokinase specific activity (*p=0.044 vs 
control). (Data are normalized for cell number; Glci = Glucose concentration at 
time 0, Glcf = Glucose concentration at time 24h). C: Similar increase of GLUT-
1 and GLUT-4 expression measured by Quantitative PCR analysis; Ratio is 
measured versus a housekeeping gene (HG, beta-2-microglobulin). 
 
Figure 2: Coordinated BV-2 cell metabolic adaptation to LPS+IFNγ activation. 
A: Glucose-6-phosphate deshidrogenase (G6PDH) specific activity normalized 
by number of cells (*p=0.004). B: Phosphofructokinase-1 (PFK) specific activity 
normalized by cell concentration (*p=0.0014) C: Lactate deshidrogenase (LDH) 
specific activity normalized by cell concentration (*p<0.0001 vs control). D: 
Lactate released by BV-2 cells (*p=0.019 vs control). E: BV-2 cell activation 
increases both Glucose uptake and its transformation to lactate. (Conc. in 
mg.dl-1. 106cell-1, and enzyme activities in U. 106cell-1).  
 
 
Figure 3: Mitochondrial membrane potential of activated and non activated 
microglial BV2 cells. Confocal image of control (A) and LPS+INFγ activated (B) 
BV-2 cells loaded with the mitochondrial membrane potential sensitive dye 
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TMRE (40x image). C: Frequency distribution of mitochondrial TMRE 
fluorescence in control and LPS+INF activated BV-2 cells.  
Figure 4: Effect of stimulation with IL-4 and inhibition of iNOS with NLA in BV-2 
cells metabolism (Data are normalized for cell number). (A) Glucose 
consumption was 30% reduced by IL-4 (*p< 0.001 vs control) in control BV2 
cells, and NLA reduced 18% glucose consumption when applied to activated 
cells (# p=0.02, LPS+IFN+NLA vs LPS+IFN) (B) Lactate release was 44% 
reduced by IL-4 (*p< 0.001 vs control) and NLA reduced 38% this lactate 
production in activated cells (# p=0.001, LPS+IFN+NLA vs LPS+IFN). (C) IL-4 
and inhibition of iNOS with NLA did not modified G6PDH activity. 
 
Figure 5. Proposed microglia-astrocyte-neuron lactate shuttle (MANLS). 
After microglia activation with LPS+IFN, glucose is mostly oxidized by 
astrocytes and microglia and converted into lactate that is taken up by neurons 
for its complete oxidation. Glutamine and glutamate synaptic removal by 
microglia fuels the tricarboxilic acid cycle to maintain mitochondrial activity and 
ATP generation. Initially the resulting ammonium facilitates carbamic acid 
synthesis for pyrimidine formation and can also be cleared as carbamic acid 
glucuronides.  
Dashed arrows: Type 1 represents glutamine and glutamate cycle. Type 2 
represent glucose metabolism. Type 3 represent non direct metabolic 
connections. Type 4 ammonia uptake. Glc: glucose, Glu: glutamate, Gln: 
glutamine, Pyr: pyruvate, Lac: lactate, G6P: glucose-6-phophate, G3P: glucose-
3-phosphate, F6P: fructose-6-phosphate, Ri5P: ribulose-5-phosphate, R5P: 
ribose-5-phosphate, KG: alpha ketoglutarate. NADPH: Nicotinamide adenine 
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dinucleotide phosphate, NTs: Nucleotides, ROS: reactive oxygen species. TCA: 
tricarboxylic acid cycle, CbA: carbamic acid, CbA-GC: glucuronic acid synthesis 
from carbamic acid. NH4+: Ammonium, CO2: carbon dioxide 
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ABSTRACT 
 
With its capacity to survey the environment and phagocyte debris, microglia 
assume a diversity of phenotypes to specifically respond through neurotrophic 
and toxic effects. While these roles are well accepted, the underlying energetic 
mechanisms associated with microglia activation remain largely unclear.  In this 
paper, microglia metabolic adaptation to ATP, NADPH,H+ and ROS production 
was investigated. To this end, in vitro studies were performed in BV-2 cells 
before and after activation with LPS+IFNγ. NO was measured as a marker of 
cell activation. Our results show that microglia activation triggers a metabolic 
reprogramming based on an increased glucose uptake and a strengthening of 
anaerobic glycolysis, as well as of the pentose pathway oxidative branch, while 
retaining the mitochondrial activity. Based on this energy commitment, microglia 
defense capacity increases rapidly as well as ribose-5-phosphate and nucleic 
acid formation for gene transcription, essential to ensure the new acquired 
functions demanded by CNS signaling. In discussion, we review the role of NO 
in this microglia energy commitment that positions cytotoxic microglia within the 
energetics of the astrocyte-neuron lactate shuttle.  
 
Key words: 
Glutamate-glutamine cycle, glycolysis, lactate, Nitric Oxide, Pentose phosphate 
pathway 
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Introduction 
 
In the central nervous system (CNS), quiescent microglia constitutes the first 
line of defense (Falsig et al. 2008) that reacts to acute damage or infectious 
agents. In a dynamic equilibrium between the lesion progression and the 
environment, microglia adopts a diversity of phenotypes ranging from the pro-
inflammatory M1 to the neurotrophic M2 (Luo and Chen 2012).  So, in response 
to a diversity of signals, the microglia transition to an activated state implies 
migration to the lesioned area, induction of phagocytosis, massive changes in 
gene expression, and reorganization of the cell phenotype to directly modify 
neuronal survival. Thus, in the same environment activated microglia interferes 
the responses of supporting cells through release of a diversity of factors 
(Kettenmann et al. 2011). 
Microglia express a broad set of genes encoding proteins that include but are 
not limited to cytokines, chemokines, neurotrophins, neurotoxic factors, and 
proteases. Depending on the intensity of damage and the time post-injury, a 
crosstalk with neurons and astrocytes induces adaptation of the microglia 
phenotype to favor debris clearance, necrosis, tissue repair or regeneration  (De 
Yebra et al. 2006). For example, with a proper timing and mode of activation, 
microglia work as efficient antigen-presenting cells that stimulate T cells and 
affect the milieu balance between neurotrophism and cytotoxicity. 
Reactive microglia mediate this diversity of processes in coordination with 
reactive astrocytes, and both cell types depend on glucose metabolism for 
feeding their activities. After glucose uptake, Hexokinase (HK; E.C. 2.7.1.1) 
mediates glucose phosphorylation, yielding glucose-6-phosphate (G6P), a 
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common precursor of glycolysis for energy and lactate production, and of the 
pentose–phosphate pathway (PPP). In microglia, the PPP not only renders 
ribose-5-phosphate for nucleic acid synthesis, but also NADPH+H+ redox 
equivalents through its oxidative branch, to be transformed at the external 
cytoplasm membrane by NADPH oxidase (E.C. 1.6.3.1) in superoxide ions for 
defense and oxidative stress (Wu et al. 2006; Yang et al. 2007). The rate-
limiting step in glycolysis activity is catalyzed by 6-phosphofructokinase (PFK1; 
E.C. 2.7.1.11), and in PPP activity by glucose-6-phosphate dehydrogenase 
(G6PD; E.C. 1.1.1.49). The interconnected reactions between these two 
pathways facilitate a direct and rapid metabolic modulation that covers at each 
moment the cell demand in these diverse end products.  
Presently, the adaptation of glucose pathways to feed microglia diversity of 
phenotypes remains unknown, and we hypothesized that it might in part mimic 
the adaptation described in astrocytes.  In astrocytes, nitric oxide (NO) 
formation triggers a very rapid PFK1 activation that potentiates anaerobic 
glycolysis versus the oxidative phosphorylation (OXPHOS). This metabolic 
transition preserves astrocytes from ATP depletion and maintains their 
mitochondrial membrane potential (Almeida et al. 2004b).  
To this end, in vitro metabolic studies were performed in BV-2 microglia, a 
suitable alternative model of primary culture (Henn et al. 2009), before and after 
activation with LPS+ IFNγ, and NO production measured in each condition 
(Blasi et al. 1990). Here we provide evidences that, associated with NO 
formation, activation of microglia triggers a metabolic reprogramming based on 
an increased glucose uptake and a potentiation of both the anaerobic glycolysis 
and the oxidative branch of PPP, while retaining a mitochondrial activity. 
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Essential to ensure the new functions of activated microglia, ribose-5-phosphate 
availability for nucleic acid synthesis and gene transcription increases rapidly as 
well as ATP, lactate and NADPH+H+. In Discussion the role of microglia lactate 
formation and glutamate uptake is considered positioned within the 
neuroenergetics of the astrocyte-neuron lactate shuttle (ANLS) (Bouzier-Sore et 
al. 2003; Magistretti 2006; Magistretti and Chatton 2005; Pellerin and Magistretti 
2012) of a four-partite synapse, in which lactate is shuttling to neurons not only 
from astrocytes but also from microglia (Rodríguez MJ 2013). 
 
Materials and methods 
 
Materials 
 
Cell line of murine BV-2 microglia was purchased from Cell Bank (Interlab Cell 
Line Collection, ICLC, Geneva, Italy).  RPMI medium supplemented with L-
glutamine was purchased from GIBCO (Oklahoma, USA). Fetal Bovine Serum 
(FBS), was from VWR Scientific (San Francisco, USA). Culture plates and 
flasks were purchased from Nunc (Roskilde, Denmark). Lipopolysaccharide 
(LPS) from Escherichia coli 0111:B4 and interferon-gamma (IFNγ) and all 
metabolites and enzyme reagents were purchased from Sigma (St. Louis, 
USA). 
 
BV-2 cell culture 
BV-2 cells were cultured in RPMI 1640 medium with L-glutamine and 
supplemented with 10% (v/v) heat-inactivated FBS, 100 U/ml penicillin and 100 
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µg/ml streptomycin. Cells were grown in a humidifier cell incubator containing 
5% CO2 at 37 °C. Before activation, cells were cultured at a density of 5 × 104 
cells/ml for 24 h and flasks were divided into 3 groups: a) One group with no 
further manipulation, called Control, b) the LPS+ IFNγ group, in which BV-2 
cells were activated with LPS+ IFNγ (0.1 µg/ml and 0.5 ng/ml respectively) for 
24 hours, and c) the IL-4 group, in which BV-2 cells were stimulated with IL-4 
(0.5 µg/ml) for 24 hours. 
 
Inhibition of NO synthesis in LPS+IFNγ stimulated BV-2 cells 
In order to inhibit NO formation, BV-2 cells activated with LPS+IFNγ were 
incubated with 2.5 mM Nω-nitro-l-arginine (NLA), a potent inhibitor of nitric 
oxide synthase (NOS) (Molnár and Hertelendy 1992). 
 
Quantification of NO and TNFα production by BV-2 cells 
NO production was assessed in culture supernatants by the Griess reaction, a 
colorimetric assay that detects nitrite (NO2−) as a stable reaction product of NO 
with molecular oxygen (Green et al., 1982). Briefly, 50 µl of each sample were 
incubated with 25 µl of Griess reagent A (1% sulfanylamide, 5% phosphoric 
acid) and 25 µl of Griess reagent B (0.1% N-1-naphthylenediamine) for 5 min. 
Sample optical density was measured at 540 nm with a microplate reader 
(Sunrise-Basic Reader, TECAN). The nitrite concentration was determined from 
a sodium nitrite standard curve. TNFα released in the cell culture supernatant 
was determined by an ELISA murine TNFα kit (PeproTech; London, UK) 
following the manufacturer's guidelines. 
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Real-time RT-PCR 
Total RNA from microglial cells was isolated using the NucleoSpin® 
RNA/Protein kit (Qiagen Inc., Hilden, Germany) according to the manufacturer's 
instructions. Then 2 µg of first-strand cDNA was synthesized with random 
primers using the First Strand cDNA Synthesis kit. The RT reaction was 
performed at 42°C for 60 minutes and then at 70°C for 5 minutes. Real-time 
PCR was conducted using SensiFAST®  SYBR No-ROX One-Step mix and 
Applied Biosystems (Foster, CA) Stem One Plus® Real Time PCR Systems 
according to manufacturer’s instructions. The PCR program was:  
2 minutes at 95°C for denaturation, subsequently 45 cycles of 15 seconds at 
95°C for amplification, and 1 minute at 60°C for final extension.. The level of 
mRNA expression was determined with a standard curve and normalized to the 
mRNA level of B2m. The PCR primer of B2m endogenous control, glucose 
transporters (GLUT) -1, -2 -3, -4, and -5, and glucokinase (GK) target genes 
were purchased from RealTimePrimers (Elkins Park PA, USA) The ΔΔCT 
method was used to analyze the data as described by Bookout et al. (2006). 
Primer sequences  for target gene and endogenous controls are presented in 
Table 1. 
 
Glucose consumption and Lactate production 
Culture medium was collected from control and LPS+IFNγ activated BV-2 cells 
at time 0 and 24 hours. Then glucose and lactate levels were determined with 
an ADVIA® 2400 Clinical Chemistry System (Siemens Healthcare Diagnostics, 
Tarrytown, USA) that uses the glucose oxidase method described by Barham 
and Trinder (Barham and Trinder 1972) and the method of Shimojo (Shimojo et 
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al. 1989) for lactate measurement. For statistical analysis of lactate release, a 
normal distribution of data was assumed (Voisin et al. 2010). 
 
Lysate preparation and enzyme activity determination 
Cells were grown to confluence, transferred to a 15 ml Falcom® tube (BD 
Biosciences, California, USA), centrifuged at 1000x g at RT for 10 min. Pelleted 
cells were washed in 10 ml PBS 10 mM PH=7.4, counted in a Neubauer 
counting chamber and centrifuged again. The pellet was suspended in enough 
amount of ice-cold lysis buffer (50 mM Tris-HCl, 4 mM EDTA, 50 mM FK, 0,1% 
(v/v) Triton X-100, PH=7) to have 107 cells/ml, transferred to a 1.5 ml centrifuge 
tube and homogeneized (Potter’s Homogeneizer) at 11000 min-1. Then, the cell 
lysate was centrifuged at 14000 g for 15 min at 4ºC. The supernatant fraction 
was transferred to a centrifuge tube and stored at 4ºC until the enzymatic assay 
was performed. 
 
The enzyme activities of HK, PFK1, G6PDH and lactate dehydrogenase (LDH; 
E.C. 1.1.1.27) were estimated spectrophotometrically in BV-2 lysate 
supernatants. The assays were performed at 30°C in 1 ml final volume 
incubation buffer added with 100 µl cell supernatant in a Beckman Coulter 
(Brea, USA) recording spectrophotometer. Then concentration of NADH or 
NADPH was monitored by measuring absorbance at 340 nm. One unit of 
enzyme activity (U) is defined as µmol/min, and specific activity is expressed as 
U/nºcells. 
 
HK activity was assayed by measuring the rate of reduction of NADP+ by 
 36 
glucose 6-phosphate dehydrogenase (Bergmeyer 1983). The assay medium 
contained Tris-HCl 50 mM, MgSO4 80 mM, EDTA 20 mM, KCI 1.5 mM, 
mercaptoethanol 2mM, NADP+ 3 mM, ATP 2.5 mM, Triethanolamine 200 mM, 
Glucose 1 mM. 
 
PFK1 activity was measured by measuring changes in the absorbance of NADH 
in a coupled enzyme assay (Beutler 1975). The assay buffer consisted of Tris-
HCl 50 mM, pH 7.4, MgCl2 100 mM, EDTA 5 mM, aldolase (mouse muscle, 
0.04 U/ml), triose phosphate isomerase (mouse muscle, 2.4 U/ml), GAPDH 
(mouse muscle, 0.32 UI/ml) and 1mM of fructose 6-phosphate and ATP. 
 
Lactate dehydrogenase activity was measured using the method previously 
described by Hakala (Hakala et al. 1956). The assay buffer consisted of Tris-
HCl 50mM PH=7.5, NADH 2 mM and pyruvate 20mM.  
 
G6PDH activity was assayed as described by Bishop (Bishop 1966). The assay 
medium contained 380 mM glycine, 304 mM hydrazine, 83 mM Lactate and 2,6 
mM NAD disodium salt. 
 
Confocal imaging of mitochondrial membrane potential  
Mitochondrial membrane potential (∆Ψm) was measured by confocal imaging of 
BV-2 cells loaded with the fluorescent probe tetramethylrhodamine ethyl ester 
(TMRE) (Molecular Probes, Eugene Oregon), as previously described (Baczkó 
et al. 2004). In brief, cells were first incubated in 6 well-plates for 30 min in 
medium containing TMRE (50 nM) and then washed with fresh medium. 
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Afterwards, cells were incubated in the presence of 50 nM TMRE during the 
imaging process. Cell fluorescence was acquired by sequential scanning at the 
510 nm emission wavelength. Cell average pixel intensity was obtained as an 
average of measurements done in 4 fields of each one of 3 culture wells. 
Confocal images were obtained using Zeiss Observer.Z1® microscope coupled 
to a Retiga EXi Fast 1394® camera, objective LD 20X/0.4 DICII (resolution 0.83 
µm). 
 
Software and Data analysis 
Statistical studies and graphics were performed with Statgraphics® (STSC Inc., 
Rockville, USA) and Graphpad Prism® (GraphPad Software Inc., La Jolla, 
USA). For each parameter, Kurtosis and Skewness moments were calculated to 
test the normal distribution of data. One-way ANOVA test was used to analyse 
differences between the groups. In all cases p<0.05 was considered statistically 
significant.  
Image acquisition was performed using Fluo4® software (Exploranova, 
Bordeaux, France). Figure 5 was produced using Servier Medical Art archive 
(Les laboratoires servier, Suresnes, France) 
 
 
Results 
 
BV-2 cell activation increases glucose uptake and its phosphorylation  
 
BV-2 cell activation was monitored by estimation of NO and TNFα release 24h 
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after activation with LPS+IFNγ. At this time, LPS+IFNγ increased 6 fold NO 
production (from 4.89± 0.85 to 29.62± 1.96 p<0.0001) and TNFα 3.5-fold (from 
534.88 ± 113.94 to 1948.58 ± 333.32 p<0.0001) when compared with controls.   
 
BV-2 glucose consumption was compared between control and LPS+INFγ 
activated cells. In both situations, glucose was measured in the culture medium 
at time 0 and 24h, and results were referred to the BV-2 cell number. After 
activation, glucose consumption increased significantly in a fold change of 1.37 
(Figure 1A, 2D). 
 
An increased energy demand requires greater microglia usage of glucose, and 
in other cells this is facilitated by the increased activity of Hexokinase to retain 
glucose within the cell, and also by the increased expression of GLUT. To 
estimate the effect of cell activation on the glucose uptake and consumption by 
microglia we determined the HK specific activity and the expression of GK and 
the five main species of GLUT. Relative to control, LPS+IFNγ promoted a 
significant 1.9-fold increase of HK specific activity in the soluble fraction of cell 
lysate (Figure 1B, 2D). BV-2 glucokinase expression was analyzed by RT-
qPCR. mRNA of this enzyme was amplified from total RNA isolated from control 
BV-2 cells, and no change was found after LPS+IFNγ activation (data not 
shown).  
 
To identify which of the five members of the GLUT family are expressed in 
microglia, mRNA of GLUT-1 to -5 was analyzed in control cells by RT-qPCR.  
GLUT-1 expression resulted largely predominant (91% of total), far from GLUT-
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4 the second in abundance (8,2% of total) (Figure 1C). The very low expression 
of GLUT-2, GLUT-3 and GLUT-5 (< 0,2% of total) was considered negligible 
(Figure 1C). 24h after LPS+IFNγ activation, both GLUT-1 and GLUT-4 
expression resulted similarly increased, but this increase was significant for 
GLUT-4 (p=0.034) and not for GLUT1 (p=0,057). GLUT-2, GLUT-3 and GLUT-5 
levels remained negligible (Figure 1C). 
 
BV-2 cell activation induces a switch of glucose metabolism to anaerobic 
glycolysis and pentose phosphate pathway. 
 
The increased glucose uptake and its phosphorylation measured in activated 
BV-2 cells may indicate an enhancement of anaerobic glycolysis, supported by 
the increased activity of PFK1, the key regulatory enzyme of the glycolytic rate. 
This enhancement is sometimes associated with an increased ROS production 
at the plasma membrane facilitated by the increased activity of G6PDH, the 
regulatory enzyme of the PPP. 
Consistent with this possibility, G6PDH specific activity was determined in the 
soluble fraction of cell lysate, together with PFK1 and LDH specific activities 
and lactate extracellular concentration. Relative to control, LPS+IFNγ activation 
promoted at 24h a significant increase of G6PDH specific activity in a 1.95 fold 
change (p=0.004, Figure 2A,D). PFK1 specific activity resulted also significantly 
increased in a 1.14 fold change (p=0.0014, Figure 2B,D), and the same 
occurred with LDH activity, increased in a fold change of 1.4 (p<0.0001, Figure 
2C,D). 
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Compared to control, lactate production was doubled in the activated cells, as 
evidenced at 24h by its 2.02-fold increased concentration in the culture medium 
(p=0.019). Besides the increased glucose uptake of the activated cells, the 
lactate level represents an increased and massive transformation of G6P into 
lactate, supported by a glucose/lactate ratio from 1.266 in controls to 1.874 in 
activated cells. 
This massive lactate production could be attributed to a reduced mitochondrial 
activity and a switch to anaerobic glycolysis of the activated cells. This was 
assessed through a time-lapse confocal imaging of the inner membrane 
potential (ΔΨm) at 24h in control and activated cells with the mitochondrial 
membrane potential sensitive dye TMRE (3A). In both situations, the frequency 
distribution of mitochondria fluorescence followed a normal distribution and was 
similar in their absolute value and relative frequency distribution (Figure 3B). 
The lack of ΔΨm difference herein found indicates that the activated cells 
maintain their electron transport chain usage besides their anaerobic glycolysis 
switch and their increased PPP.  
 
NO formation participates of the activated BV-2 cells glycolitic activation 
 
Involvement of NO in the metabolic reprogramming of LPS+IFNγ activated BV-2 
cells was studied after 2’5 mM Nω-nitro-l-arginine inhibition of iNOS for 24h. 
Glucose and lactate were measured in the culture medium at time 0 and 24h, 
and results referred to the BV-2 cell number. iNOS inhibition resulted in a 
decreased of both glucose consumption (fold change of 0.82, p=0.02) and 
lactate release (fold change of 0.63, p<0.001) (Figure 4A, B), back to control 
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values. No significant change in G6PDH was found (Figure 4C), indicating that 
its activation is independent from NO.  
 
BV-2 cells adoption of a phagocytic phenotype activates a new metabolic 
reprogramming  
 
To determine whether our results also apply to the adoption of a phagocytic 
phenotype, BV-2 cells were stimulated with IL-4 (0.5 µg/ml) for 24h.  Glucose 
and Lactate were both measured in the culture medium at time 0 and 24h, and 
G6PDH activity in the homogenate as usually. With regard to control, glucose 
consumption was 30% reduced (p< 0.001) and lactate production 43% (p< 
0.006), whereas G6PDH activity resulted unchanged. In these conditions, the 
maintenance of the PPP ensures NADPH+H+ redox equivalents to be 
transformed in superoxide ions for phagocytosis as G6DPH strongly increases 
its activity with higher NADP+ level. The new biomolecules delivered by 
phagocytosis directly available to the BV-2 cells would reduce at least in part 
the need of anabolic reactions and thus the cell energy demand. This possibility 
requires further experiments to be validated. 
 
Discussion 
BV- 2 cells were used to investigate the microglia adaptation to an excitotoxic 
phenotype. This cell line is considered a suitable alternative model of primary 
culture or of many animal studies (Henn et al. 2009) (Stansley et al. 2012). For 
example, 90% of the genes induced in BV-2 by LPS activation are also found in 
primary microglia, including the Nitric Oxide synthase (iNOS) gene. 24h after 
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incubation with LPS+IFNγ, BV-2 cells increased NO and TNFα production that 
is related with an enhancement of cell inflammatory activity (Ortega et al. 2013).  
In these conditions, the main finding of this study is the coordinated response of 
the glucose pathways necessary to cover the cell demand and enable the 
microglia response to activation. This metabolic reprogramming is different with 
microglia adoption of a phagocytic phenotype as the delivery of new 
biomolecules may reduce the cell energy demand. In astrocytes LPS 
stimulation induced NO production leading to an increased glucose 
consumption and lactate release (Bolaños et al. 1994) and an increased PPP 
activity to prevent glutathione depletion and increase astrocyte resistance to NO 
mediated cellular damage (García-Nogales et al. 1999). After exposure to 
peroxinitrite, the maintenance of astrocyte mitochondrial activity and its 
reduction in neurons also demonstrates the astrocytic resistance capacity to NO 
damage (Bolaños et al. 1995). The direct NO participation in the microglia 
metabolic reprogramming shown by our data reinforces the similarity with the 
astrocyte metabolic adaptation to excitotoxicity. As such, the increased HK 
activity and increased GLUT1 and GLUT4 expression ensure enough glucose 
availability to the cell. GLUT1 expression in control microglia was much higher 
than GLUT4, with similar changes 24h after activation. Because of that, these 
two transporters can be considered constitutive of microglia.  
  
GLUT1 is a high-affinity glucose transporter, which expression in tumor cells is 
stimulated under hypoxic conditions. And this adaptation also includes 
enhancement of the glycolysis rate to support the increased energy demand of 
the proliferative cells (Bashan et al. 1992; Haber et al. 1998). The HK and 
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GLUT1 increases herein found would then reflect the microglia adaptation to an 
enhanced glycolytic demand with a high lactate production, and high metabolic 
rate. GLUT4 expression is modulated in brain and pancreas by ATP dependent 
potassium (KATP) channels whose activity depends on glucokinase (Choeiri et 
al. 2006). In agreement with previous brain studies (Alvarez et al. 2002) the low 
glucokinase Km that renders the enzyme unable to detect glucose 
concentration increase may explain the unchanged glucokinase expression in 
activated microglia. The increased KATP channel expression described in 
activated microglia (Ortega et al. 2012; Ramonet et al. 2004b) may then 
participate in the GLUT4 expression increase. If true, the similar changes of 
GLUT1 and GLUT4 shown by our results suggest a coordinated microglia 
control of their expression that may depend, at least in part, on KATP channel 
activity. As observed in taste cells (Yee et al. 2011), this would represent a fine 
coordination between activation of microglia and increased glucose availability.  
 
Microglia metabolic reprogramming led to a potentiation of anaerobic glycolysis 
reflected by the increased PFK1 and LDH activities and a massive lactate 
formation. In astrocytes increased NO stimulates PFK1 activity through 
allosteric activation with fructose-2,6-bisphosphate (Fru-2,6-P2) produced by 6-
phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Moreover, NO inhibition 
of cytochrome c oxidase switches the glycolytic rate on, with pyruvate 
conversion into lactate recovering NAD+ in the cytosol for glycolysis feed-back 
(Almeida et al. 2004a). The supply of glucose-derived lactate by activated 
microglia would support active neurons, whose elevated energy demand relies 
mostly on mitochondrial ATP production. Thus, with the astrocytes and 
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microglia adapted to a major glucose anaerobic oxidation, lactate represents 
the major neuronal energy source in damaged CNS (Fig 5).  
 
The NO-mediated down-regulation of mitochondrial energy production observed 
in neurons and initially in astrocytes (Bolaños et al. 1994), but afterwards 
considered to be unaffected by the same authors, with similar activities of the 
enzymatic complexes of the Krebs cycle  (Bolaños et al. 1995) was not truly 
observed in microglia. The similar ΔΨm of control and activated BV-2 cells might 
reflect the ATP synthase reversed reaction fed by ATP from glycolysis and 
others (Almeida et al. 2001 PNAS), or could indicate an active electron 
transport chain energy production.  In microglia of damaged brain tissue, the 
higher number of mitochondria labeled with [H3]PK11195 (Bernal et al. 2009; 
De Yebra et al. 2006) and their higher KATP channels expression (Rodríguez MJ 
2013; Virgili et al. 2011) argue in favor of a significant mitochondrial production 
of energy to help ensuring sufficient bioenergetics to execute the new 
transcription programs derived from excitotoxic activation. If true, feeding of the 
Krebs cycle to maintain mitochondria activity cannot rely on pyruvate because 
of its transformation into lactate, but on 2-oxoglutarate formation from glutamate 
and glutamine deamination that increases progressively from apoptotic to 
necrotic damage (Ramonet et al. 2004a).   
Upon activation, microglia express the two glutamate transporters EAAT-1 and -
2 for glutamate and glutamine synaptic extrusion as well as glutamine synthase 
(Gras et al. 2006). Thus, in excitotoxicity, the fast microglial uptake of glutamate 
and glutamine, coordinated with the astrocyte glutamate removal, promotes a 
quick deactivation of the increased synaptic glutamate signal. In astrocytes, the 
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early work by Pellerin et al (1994) describes the glutamate-induced glycolysis to 
facilitate lactate to neurons during physiological activation, and hypothesized for 
the first time the ANLS. With excitotoxicity, microglia glutamate uptake would 
induce a similar stimulatory effect to provide further lactate to neurons, and also 
renders abundant 2-oxoglutarate to ensure the Krebs cycle activity. 
In microglia glutamate deamination renders 2-oxoglutarate and ammonium that, 
combined with CO2 released from the Krebs cycle, forms carbamic acid, a 
precursor of the pyrimidine bases necessary for nucleic acid synthesis and the 
increased gene expression. As in astrocytes (Gradinaru et al. 2012), carbamic 
acid direct clearance and elimination as a stable complex with glucuronides is 
also possible through a detoxification process (Hipkiss 2010; Schafer et al. 
2013).  
In necrotic brain tissue a net glutamine output of the Glutamate/Glutamine cycle 
caused by a reduced neuronal glutaminase activity (Ramonet et al. 2004a) 
increases the microglial formation of 2-oxoglutarate and ammonium and the 
generation of superoxide ions. After reaction with NO, superoxide ions form the 
highly reactive peroxynitrite products, associated with a cytotoxic microglia 
phenotype, and a progressive microglia dysfunction. (Svoboda and 
Kerschbaum 2009). If true, microglia ammonium concentration would represent 
one of the contextual factors that influence the microglial net effects on neuronal 
survival (Luo and Chen 2012) (See Fig. 5). 
The PPP oxidative branch was also increased in activated microglia, as shown 
by the increased G6PDH activity that supports G6P oxidation and NADPH 
formation. In neurons NO facilitates a fine-tuning of G6P destination to 
glycolysis or PPP that potentiates glutathione reduction against oxidative 
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damage. Our data indicate that NO is also directly involved in the metabolic 
reprogramming of microglia, together with a significant contribution of the 
phagosomal NADPH-oxidase to ROS generation and oxidative stress damage 
from G6P (Miller et al. 2007; Wu et al. 2006). Furthermore, the juxtaposition of 
phagosomes and mitochondria recently proposed in microglia (Rodríguez MJ 
2013) should potentiate mitochondrial ROS formation and energy production 
(Dikalov et al. 2012; Murphy 2009) (See Fig. 5).  
 
In conclusion, NO appears to play a key role in the adaptation of activated 
microglia to the energy commitment necessary to ensure its adoption of a 
neurotrophic/cytotoxic phenotype. In these conditions, the coordinated response 
of the four-partite synapse, in which lactate is shuttling to neurons not only from 
astrocytes but also from microglia, has also to include the rapid glutamate 
removal by astrocytes and microglia. Thus, under brain damage, a new player 
should be included in the ANLS initially proposed by Pelerin et al. (1994), 
transforming it into a microglia-astrocyte-neuron lactate shuttle. Further studies 
are needed to determine how reduction of glutaminase activity following 
neuronal damage and the consequent increased ammonium output influence 
the microglia response of increased oxidative damage.  
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Figure legends 
 
Figure 1: 24h after LPS+INFγ activation, the BV-2 increased glucose 
consumption is facilitated by the coordinated increase of hexokinase activity 
and GLUT-1 and GLUT-4 expression. A: Increase of Glucose consumption 
(*p<0.0001 vs control) B: Increase of Hexokinase specific activity (*p=0.044 vs 
control). (Data are normalized for cell number; Glci = Glucose concentration at 
time 0, Glcf = Glucose concentration at time 24h). C: Similar increase of GLUT-
1 and GLUT-4 expression measured by Quantitative PCR analysis; Ratio is 
measured versus a housekeeping gene (HG, beta-2-microglobulin). 
 
Figure 2: Coordinated BV-2 cell metabolic adaptation to LPS+IFNγ activation. 
A: Glucose-6-phosphate deshidrogenase (G6PDH) specific activity normalized 
by number of cells (*p=0.004). B: Phosphofructokinase-1 (PFK) specific activity 
normalized by cell concentration (*p=0.0014) C: Lactate deshidrogenase (LDH) 
specific activity normalized by cell concentration (*p<0.0001 vs control). D: 
Lactate released by BV-2 cells (*p=0.019 vs control). E: BV-2 cell activation 
increases both Glucose uptake and its transformation to lactate. (Conc. in 
mg.dl-1. 106cell-1, and enzyme activities in U. 106cell-1).  
 
 
Figure 3: Mitochondrial membrane potential of activated and non activated 
microglial BV2 cells. Confocal image of control (A) and LPS+INFγ activated (B) 
BV-2 cells loaded with the mitochondrial membrane potential sensitive dye 
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TMRE (40x image). C: Frequency distribution of mitochondrial TMRE 
fluorescence in control and LPS+INF activated BV-2 cells.  
Figure 4: Effect of stimulation with IL-4 and inhibition of iNOS with NLA in BV-2 
cells metabolism (Data are normalized for cell number). (A) Glucose 
consumption was 30% reduced by IL-4 (*p< 0.001 vs control) in control BV2 
cells, and NLA reduced 18% glucose consumption when applied to activated 
cells (# p=0.02, LPS+IFN+NLA vs LPS+IFN) (B) Lactate release was 44% 
reduced by IL-4 (*p< 0.001 vs control) and NLA reduced 38% this lactate 
production in activated cells (# p=0.001, LPS+IFN+NLA vs LPS+IFN). (C) IL-4 
and inhibition of iNOS with NLA did not modified G6PDH activity. 
 
Figure 5. Proposed microglia-astrocyte-neuron lactate shuttle (MANLS). 
After microglia activation with LPS+IFN, glucose is mostly oxidized by 
astrocytes and microglia and converted into lactate that is taken up by neurons 
for its complete oxidation. Glutamine and glutamate synaptic removal by 
microglia fuels the tricarboxilic acid cycle to maintain mitochondrial activity and 
ATP generation. Initially the resulting ammonium facilitates carbamic acid 
synthesis for pyrimidine formation and can also be cleared as carbamic acid 
glucuronides.  
Dashed arrows: Type 1 represents glutamine and glutamate cycle. Type 2 
represent glucose metabolism. Type 3 represent non direct metabolic 
connections. Type 4 ammonia uptake. Glc: glucose, Glu: glutamate, Gln: 
glutamine, Pyr: pyruvate, Lac: lactate, G6P: glucose-6-phophate, G3P: glucose-
3-phosphate, F6P: fructose-6-phosphate, Ri5P: ribulose-5-phosphate, R5P: 
ribose-5-phosphate, KG: alpha ketoglutarate. NADPH: Nicotinamide adenine 
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dinucleotide phosphate, NTs: Nucleotides, ROS: reactive oxygen species. TCA: 
tricarboxylic acid cycle, CbA: carbamic acid, CbA-GC: glucuronic acid synthesis 
from carbamic acid. NH4+: Ammonium, CO2: carbon dioxide 
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Tables 
Table 1: Primer and probe sequences for real-time RT-PCR 
 
Target  Gene Sequence (5’-3’) Size (bp) Accesion N 
Slc2a1 Mouse GLUT-1 
 
F: TGC CAA GCT AAT CTG TAG GG 
R: GAA TGG GCG AAT CCT AAA AT 
163 NM_011400 
Slc2a2 Mouse GLUT-2 F: AAG ACA AGA TCA CCG GAA CC 
R: TGG TGT TGT GTA TGC TGG TG 
224 NM_031197 
Slc2a3 Mouse GLUT-3 
 
F: TTT TCC ACA GGT CAC TGG AT 
R: GTT AGA GGA GTC GCC TTT CC 
204 NM_011401 
Slc2a4 Mouse GLUT-4 
 
F: TCC CTT TTA GAG CAG GAG GT 
R: ACA GGG AAG AGA GGG CTA AA 
152 NM_009204 
Slc2a5 Mouse GLUT-5 
 
F: GAC ACT CCC TGC TGA AGA AA 
R: CCG TAG AAG ACA CCA CAT CC 
241 NM_019741 
GK Mouse Glucokinase F: GCC AAA AAC ACG TAT GGA AC  
R: AGC TAT AGC CAC GGA ACC TT  
153 NM_008194 
B2m Beta-2 microglobulin F: GGC CTG TAT GCT ATC CAG AA 
R: GAA AGA CCA GTC CTT GCT GA 
198 NM_009735 
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